Bausch Health Companies (BHC) Non-Current Debt (2009 - 2026)

Bausch Health Companies (BHC) reported Non-Current Debt of $20.8 billion for Q1 2026, down 3.47% on a YoY basis from $21.5 billion in Q1 2025, and little changed sequentially from $20.8 billion in Q4 2025.

Bausch Health Companies (BHC) Non-Current Debt (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Non-Current Debt data on file, last reported at $20.8 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt fell 3.47% year-over-year to $20.8 billion; the trailing twelve-month figure through Mar 2026 stood at $20.8 billion (down 3.47% YoY), and the FY2025 full-year result was $20.8 billion, up 9.9% from the prior year.
  • Non-Current Debt held at $20.8 billion in Q1 2026, from $20.8 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $23.2 billion in Q1 2022 to a low of $18.9 billion in Q4 2024.
  • A 5-year average of $21.2 billion and a median of $21.2 billion in 2024 frame the typical range for Non-Current Debt.
  • Across the five-year window, Non-Current Debt decreased 13.66% in 2024 and climbed 9.9% in 2025, its largest moves.
  • Tracing BHC's Non-Current Debt over 5 years: stood at $20.8 billion in 2022, then climbed by 5.64% to $21.9 billion in 2023, then declined by 13.66% to $18.9 billion in 2024, then climbed by 9.9% to $20.8 billion in 2025, then dropped by 0.25% to $20.8 billion in 2026.
  • Business Quant data shows BHC's Non-Current Debt at $20.8 billion in Q1 2026, $20.8 billion in Q4 2025, and $20.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn 20.76 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 20.76 Bn
Dec 31, 2025 20.82 Bn
Sep 30, 2025 20.46 Bn
Jun 30, 2025 21.74 Bn
Mar 31, 2025 21.51 Bn
Dec 31, 2024 18.94 Bn
Sep 30, 2024 21.51 Bn
Jun 30, 2024 21.21 Bn
Mar 31, 2024 21.54 Bn
Dec 31, 2023 21.94 Bn
Sep 30, 2023 22.43 Bn
Jun 30, 2023 20.11 Bn
Mar 31, 2023 20.65 Bn
Dec 31, 2022 20.77 Bn
Sep 30, 2022 20.80 Bn
Jun 30, 2022 21.81 Bn
Mar 31, 2022 23.17 Bn
Dec 31, 2021 22.65 Bn
Sep 30, 2021 22.36 Bn
Jun 30, 2021 23.44 Bn